Lixte Biotechnology closed down 16% on Wednesday after it planned to invest 25% of its treasury funds in cryptocurrencies.
-
最新报道：According to Yahoo Finance data, clinical-stage pharmaceutical company Lixte Biotechnology (ticker: LIXT) closed down 16% on Wednesday at $4.06 per share. This follows the company's announcement of plans to allocate up to 25% of its reserves to Bitcoin. The LIXT sell-off comes as investors appear to be shifting from Bitcoin to Ethereum reserve companies, as ETH has recently outperformed the world's oldest cryptocurrency, benefiting from market tailwinds. Bitcoin reserve companies were popular until recently, but a wave of new companies holding ETH has clearly fueled ETH's recent gains. "2025 is the year of the Ethereum reserve strategy," said Danny Nelson, a research analyst at Bitwise, in an interview.
下一篇
BTC price falls below $122,000, up 2.13% in 24 hours
- According to BOSS Wallet data, Bitcoin price today: BTC price has dropped to $121,953.26, ...
24小时热点
热点专题
418154